Suppr超能文献

粒子治疗协作组头颈亚委员会关于头颈部肿瘤治疗的粒子治疗共识指南。

PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors.

作者信息

Lin Alexander, Chang John H C, Grover Ryan S, Hoebers Frank J P, Parvathaneni Upendra, Patel Samir H, Thariat Juliette, Thomson David J, Langendijk Johannes A, Frank Steven J

机构信息

University of Pennsylvania, Philadelphia, PA, USA.

Oklahoma Proton Center, Oklahoma City, OK, USA.

出版信息

Int J Part Ther. 2021 Jun 25;8(1):84-94. doi: 10.14338/IJPT-20-00071.1. eCollection 2021 Summer.

Abstract

PURPOSE

Radiation therapy is a standard modality in the treatment for cancers of the head and neck, but is associated with significant short- and long-term side effects. Proton therapy, with its unique physical characteristics, can deliver less dose to normal tissues, resulting in fewer side effects. Proton therapy is currently being used for the treatment of head and neck cancer, with increasing clinical evidence supporting its use. However, barriers to wider adoption include access, cost, and the need for higher-level evidence.

METHODS

The clinical evidence for the use of proton therapy in the treatment of head and neck cancer are reviewed here, including indications, advantages, and challenges.

RESULTS

The Particle Therapy Cooperative Group Head and Neck Subcommittee task group provides consensus guidelines for the use of proton therapy for head and neck cancer.

CONCLUSION

This report can be used as a guide for clinical use, to understand clinical trials, and to inform future research efforts.

摘要

目的

放射治疗是头颈部癌症治疗的标准方式,但会带来显著的短期和长期副作用。质子治疗具有独特的物理特性,可减少对正常组织的剂量,从而减少副作用。目前质子治疗正用于头颈部癌症的治疗,越来越多的临床证据支持其应用。然而,更广泛采用的障碍包括可及性、成本以及对更高级别证据的需求。

方法

本文回顾了质子治疗用于头颈部癌症治疗的临床证据,包括适应证、优势和挑战。

结果

粒子治疗协作组头颈部小组委员会任务组提供了质子治疗头颈部癌症的共识指南。

结论

本报告可作为临床应用指南,用于理解临床试验,并为未来的研究工作提供信息。

相似文献

1
PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors.
Int J Part Ther. 2021 Jun 25;8(1):84-94. doi: 10.14338/IJPT-20-00071.1. eCollection 2021 Summer.
2
Consensus Statement on Proton Therapy for Prostate Cancer.
Int J Part Ther. 2021 Apr 12;8(2):1-16. doi: 10.14338/IJPT-20-00031.1. eCollection 2021 Fall.
3
Consensus Statement on Proton Therapy in Mesothelioma.
Pract Radiat Oncol. 2021 Mar-Apr;11(2):119-133. doi: 10.1016/j.prro.2020.05.004. Epub 2020 May 24.
4
Clinical Review of Proton Therapy in the Treatment of Unilateral Head and Neck Cancers.
Int J Part Ther. 2021 Jun 25;8(1):248-260. doi: 10.14338/IJPT-D-20-00055.1. eCollection 2021 Summer.
5
PTCOG Gastrointestinal Subcommittee Lower Gastrointestinal Tract Malignancies Consensus Statement.
Int J Part Ther. 2024 Apr 26;11:100019. doi: 10.1016/j.ijpt.2024.100019. eCollection 2024 Mar.
6
Proton Therapy in The Treatment of Head And Neck Cancers- Review.
Curr Oncol Rep. 2024 Nov;26(11):1380-1387. doi: 10.1007/s11912-024-01592-9. Epub 2024 Aug 8.
7
Proton Radiotherapy to Reduce Late Complications in Childhood Head and Neck Cancers.
Int J Part Ther. 2021 Jun 25;8(1):155-167. doi: 10.14338/IJPT-20-00069.1. eCollection 2021 Summer.
8
The future of Cochrane Neonatal.
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.

引用本文的文献

1
Hybrid proton planning combining spread-out Bragg peak beams with transmission beams to shorten field delivery times while maintaining plan quality.
Phys Imaging Radiat Oncol. 2025 Jul 11;35:100809. doi: 10.1016/j.phro.2025.100809. eCollection 2025 Jul.
2
ACR-ARS Practice Parameter for the Performance of Proton Beam Therapy.
Int J Part Ther. 2024 Apr 25;13:100021. doi: 10.1016/j.ijpt.2024.100021. eCollection 2024 Sep.
3
Particle Therapy: Clinical Applications and Biological Effects.
Life (Basel). 2022 Dec 9;12(12):2071. doi: 10.3390/life12122071.

本文引用的文献

2
Quality of Life of Postoperative Photon versus Proton Radiation Therapy for Oropharynx Cancer.
Int J Part Ther. 2018 Fall;5(2):11-17. doi: 10.14338/IJPT-18-00032.1. Epub 2018 Nov 30.
3
Clinical results of proton therapy reirradiation for recurrent nasopharyngeal carcinoma.
Acta Oncol. 2019 Sep;58(9):1238-1245. doi: 10.1080/0284186X.2019.1622772. Epub 2019 Jun 3.
4
A competing risk nomogram to predict severe late toxicity after modern re-irradiation for squamous carcinoma of the head and neck.
Oral Oncol. 2019 Mar;90:80-86. doi: 10.1016/j.oraloncology.2019.01.022. Epub 2019 Feb 8.
5
A Model-Based Approach to Predict Short-Term Toxicity Benefits With Proton Therapy for Oropharyngeal Cancer.
Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):553-562. doi: 10.1016/j.ijrobp.2018.12.055. Epub 2019 Jan 6.
6
The Insurance Approval Process for Proton Radiation Therapy: A Significant Barrier to Patient Care.
Int J Radiat Oncol Biol Phys. 2019 Jul 15;104(4):724-733. doi: 10.1016/j.ijrobp.2018.12.019. Epub 2018 Dec 14.
7
Insurance Approval for Proton Beam Therapy and its Impact on Delays in Treatment.
Int J Radiat Oncol Biol Phys. 2019 Jul 15;104(4):714-723. doi: 10.1016/j.ijrobp.2018.12.021. Epub 2018 Dec 14.
8
Proton Facility Economics: Single-Room Centers.
J Am Coll Radiol. 2018 Dec;15(12):1704-1708. doi: 10.1016/j.jacr.2018.07.020. Epub 2018 Aug 26.
10
Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus Proton Therapy for Oropharyngeal Squamous Cell Carcinoma.
Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):875-882. doi: 10.1016/j.ijrobp.2018.04.018. Epub 2018 Apr 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验